Biomarkers of exposure and potential harm in adult smokers of 3–7 mg tar yield (Federal Trade Commission) cigarettes and in adult non-smokers

References

• Baker RB, Lewis LS. Filter ventilation — has there been a ‘cover-up’?. Recent Advances in Tobacco Sciences 1997; 23: 152–196
   Google Scholar
• Baker RR. Smoke chemistry. Tobacco production, chemistry and technology, DL Davis, MT Nielsen. CORESTA, Oxford 1999; 398–439
   Google Scholar
• Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Annals of Internal Medicine 2003; 138: 891–897
   PubMed Web of Science ®Google Scholar
• Benowitz NL. The use of biologic fluid samples in assessing tobacco smoke consumption. NIDA Research Monograph No. 48, J Grabowski, CS Bell, 1983; 6–26
   Google Scholar
• Benowitz NL. Biomarkers of environmental tobacco smoke exposure. Environmental Health Perspectives 1999; 107(Suppl. 2)349–355
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Jacob P, Fong I, Gupta S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. Journal of Pharmacology and Experimental Therapy 1994; 268: 296–303
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Jacob P, Jones RT, Rosenberg J. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. Journal of Pharmacology and Experimental Therapy 1982; 221: 368–372
   PubMed Web of Science ®Google Scholar
• Bessard J, Cracowski JL, Stanke-Labesque F, Bessard G. Determination of isoprostaglandin F2αtype III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay. Journal of Chromatography B 2001; 754: 333–343
   PubMed Web of Science ®Google Scholar
• Boswell CS, Curvall M, Elswick RK, Jr, Leyden DE. Modeling nicotine intake in smokers and snuff users using biological fluid nicotine metabolites. Biomarkers 2000; 5: 341–354
   PubMed Web of Science ®Google Scholar
• Bridges RB, Combs JG, Humble JW, Turbek JA, Rehm SR, Haley NJ. Puffing topography as a determination of smoke exposure. Pharmacology and Biochemistry Behaviour 1990; 37: 29–39
   PubMed Web of Science ®Google Scholar
• Burtis CA, Ashwood ER, editors. 1999. Tietz textbook of clinical chemistry. Philadelphia, PA: W. B. Saunders. p. 1245.
   Google Scholar
• Byrd GD, Davis RA, Caldwell WS, Robinson JH, deBethizy JD. A further study of FTC yield and nicotine absorption in smokers. Psychopharmacology 1998; 139: 291–299
   PubMed Web of Science ®Google Scholar
• Byrd GD, Robinson JH, Caldwell WS, deBethizy JD. Comparison of measured and FTC-predicted nicotine uptake in smokers. Psychopharmacology 1995; 122: 95–103
   PubMed Web of Science ®Google Scholar
• Chehne F, Oguogho A, Lupattelli G, Budinsky AC, Palumbo B, Sinzinger H. Increase of isoprostane 8-epi-PGF2a after restarting smoking. Leukocytes and Essential Fatty Acids 2001; 64: 307–310
   PubMed Web of Science ®Google Scholar
• Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W. Serum cholesterol concentration and coronary heart disease in populations with low cholesterol concentrations. British Medical Journal 1991; 303: 276–282
   PubMed Web of Science ®Google Scholar
• Cracowski JL, Durand T, Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends in Pharmacology Sciences 2002; 23: 360–366
   PubMed Web of Science ®Google Scholar
• Curvall M, Kazemi-Vala E, Englung G. Conjugation pathways in nicotine metabolism. Effects of nicotine on biological systems, F Adlkofer, K Thurau. Birkhauser, Basel 1991; 69–74
   Google Scholar
• Cushman M, Legault C, Barrett-Connor E, Stefanick ML, Kessler C, Judd HL, Sakkinen PA, Tracy RP. Effect of postmenopausal hormones on inflammation-sensitive proteins, The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation 1999a; 100: 717–722
   PubMed Web of Science ®Google Scholar
• Cushman M, Meilahn EN, Psaty BM, Kuller LH, Dobs AS, Tracy P. Hormone replacement therapy, inflammation and hemostasis in elderly women. Arteriosclerosis and Thrombosis Vascular Biology 1999b; 19: 893–899
   PubMed Web of Science ®Google Scholar
• Eliasson B, Hjalmarson A, Kruse E, Landfeldt B, Westin A. Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine and Tobacco Research 2001; 3: 249–255
   PubMedGoogle Scholar
• FDA 2001. Guidance for industry, bioanalytical method validation. May ( available at: http://www.fda.gov/cder/guidance/4252fnl.pdf, accessed on 21 January 2004).
   Google Scholar
• Federal Trade Commission. Cigarettes. Testing for tar and nicotine content — statements for consideration. Federal Register 1967; 32: 11178
   Google Scholar
• FitzGerald GA, Pedersen AK, Patrono C. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. Circulation 1983; 67: 1174–1177
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparation ultracentrifuge. Clinical Chemistry 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Gill JC. Transfusion principles for congenital coagulation disorders. Hematology: basic principles and practice2nd edn, R Hoffman. Churchill Livingtone, New York 1995; 2029–2038
   Google Scholar
• Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High-density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. American Journal of Medicine 1977; 62: 707–714
   PubMed Web of Science ®Google Scholar
• Green CR, Rodgman A. The Tobacco Chemists’ Research Conference: a half century forum for advances in analytical methodology of tobacco and its products. Recent Advances in Tobacco Science 1996; 22: 131–304
   Google Scholar
• Hofer I, Nil R, Battig K. Nicotine yield as determinant of smoke exposure indicators and puffing behavior. Pharmacology and Biochemistry Behaviour 1991; 40: 139–149
   PubMed Web of Science ®Google Scholar
• Kinser RD, Nelson BL, Roethig H-J, Walk R, Oey J, Tricker AR, Leyden DE. 2002. Assessment of human exposure to cigarette smoke constituents: pilot study results for carbon monoxide. Toxicology Science 66(Suppl. 1): abstract LB94:26 ( poster available at: http://www.ehcss-science.com, accessed on 21 January 2004).
   Google Scholar
• Klesges LM, Klesges RC, Cigrang JA. Discrepancies between self-reported smoking and carboxyhaemoglobin: an analysis of the second National Health and Nutrition Survey. American Journal of Public Health 1992; 82: 1026–1029
   PubMed Web of Science ®Google Scholar
• Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237–242
   PubMed Web of Science ®Google Scholar
• Maxwell JC, Fenstermacher SD. 1999. The Maxwell consumer report. March. Richmond, VA: Davenport.
   Google Scholar
• Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987; ii: 986–988
   Google Scholar
• Morrow JD, Zackert WE, Van der Ende DS, Reich EE, Terry ES, Cox B, Sanchez SC, Montine TJ, Roberts LJ. Quantification of isoprostanes as indicators of oxidant stress in vivo. Handbook of antioxidants, E Cardenas, L Packer. Marcel Decker, New York, NY 2002; 57–74
   Google Scholar
• Muscat JE, Harris RE, Haley NJ, Wynder EL. Cigarette smoking and plasma cholesterol. American Heart Journal 1991; 121: 141–147
   PubMed Web of Science ®Google Scholar
• Nelson DE, Kirkendall RS, Lawton RL, Chrismon JH, Merritt RK, Arday DA, Giovino GA. Surveillance for smoking-attributable mortality and years of potential life lost; by state — United States, 1990. Morbidity and Mortality Weekly Report (CDC) 1994; 43: 1–8
   Google Scholar
• Pace N, Strajman E, Walker EL. Acceleration of carbon monoxide elimination in man by high pressure oxygen. Science 1950; 111: 652–654
   PubMed Web of Science ®Google Scholar
• Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Advances in Immunology 1983; 34: 141–212
   PubMed Web of Science ®Google Scholar
• Pilacik B, Nofer TW, Wasowicz W. F2-isoprostanes biomarkers of lipid peroxidation: their utility in evaluation of oxidative stress induced by toxic agents. International Journal of Occupational and Medical Environmental Health 2002; 15: 19–27
   PubMedGoogle Scholar
• Pillsbury HC, Bright CC, O'Connor KJ, Irish FW. Tar and nicotine is cigarette smoke. Journal Association of Official Analytical Chemists 1969; 52: 458–462
   Google Scholar
• Proudfoot J, Barden A, Mori TA, Burke V, Croft KD, Beilin LJ, Puddey IB. Measurement of urinary F2-isoprostanes as markers of in vivo lipid peroxidation — a comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Annals of Biochemistry 1999; 72: 209–215
   Google Scholar
• Ridker PM, Haughie P. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. Journal of Investigative Medicine 1998; 46: 391–395
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Clearfield M Downs JR, Weis SE, Miles JS, Gotto AM, Jr: Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. 2001. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. New England Journal of Medicine 344:1959–1965.
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis: an inflammatory disease. New England Journal of Medicine 1999; 340: 115–126
   PubMed Web of Science ®Google Scholar
• Schepers G (February, 2002) , Demetriou D. 2002. Determination of nicotine and its metabolites in urine by HPLC after DETBA derivatization. Poster #RP-56 presented at the 8th Annual Meeting of the Society for Research on Nicotine and Tobacco, Savannah, GA, USA.
   Google Scholar
• Schoenborn CA, Adams PF, Barnes PPM, Vickerie JL, Schiller JS. Health behaviors of adults: United States, 1999–2001. Hyattsville, MD: National Center for Health Statistics. Vital Health Statistics 2004; 10: 27–32
   Google Scholar
• Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screens of the Multiple Risk Factor Intervention Trial (MRFIT). Journal of the American Medical Association 1986; 256: 823–828
   Web of Science ®Google Scholar
• Stratton K, Shetty P, Wallace R, Bondurant S, editors. 2001. Clearing the smoke. Assessing the science base for tobacco harm reduction. Washington, DC: National Academy Press.
   Google Scholar
• Tobacco Institute Testing Laboratory. Market sample 43 test results. ‘Tar’, nicotine’, and carbon monoxide values. TITL, Rockville, MD 2001
   Google Scholar
• Tracy RP, Psaty BM, Macy E, Bovill EG, Cushman M, Cornell ES, Kuller LH. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arteriosclerosis and Thrombosis Vascular Biology 1997; 17: 2167–2176
   PubMed Web of Science ®Google Scholar
• Ueda K, Kawachi I, Nakamura M, Nogami H, Shirokawa N, Masui S, Okayama A, Oshima A. Cigarette nicotine yields and nicotine intake among Japanese male workers. Tobacco Control 2002; 11: 55–60
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services. 1989. Reducing the health consequences of smoking: 25 years of progress. A report of the Surgeon General. DHHS Publication No. (CDC) 89–8411. Rockville, MD: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
   Google Scholar
• Varon J, Marik PE, Fromm RE, Gueler A. Carbon monoxide poisoning: a review for clinicians. Journal of Emergency Medicine 1999; 7: 87–93
   Google Scholar
• Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. Journal of Clinical Investigation 1991; 91: 1351–1357
   Web of Science ®Google Scholar
• Wilkins J, Gallimore JR, Moore EG, Pepys MB. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. Clinical Chemistry 1998; 44: 1358–1361
   PubMed Web of Science ®Google Scholar
• World, Health Organization. 1999. Carbon monoxide, 2nd edn. Environmental Health Criteria No. 213. Geneva: WHO.
   Google Scholar
• Yarnell JW, Sweetnam PM, Rumley A, Lowe GD. Lifestyle and hemostatic risk factors for ischemic heart disease: the Caerphilly study. Arteriosclerosis and Thrombosis Vascular Biology 2000; 20: 271–279
   PubMed Web of Science ®Google Scholar